Go Pro

QT Imaging (QTI) Competitors

QT Imaging logo
$2.91 +0.13 (+4.68%)
As of 08/21/2026 04:00 PM Eastern

QTI vs. INGN, KRMD, APYX, MBOT, and KEQU

Should you buy QT Imaging stock or one of its competitors? QT Imaging's main competitors and comparable companies include Inogen (INGN), KORU Medical Systems (KRMD), Apyx Medical (APYX), Microbot Medical (MBOT), and Kewaunee Scientific (KEQU). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does QT Imaging compare to Inogen?

QT Imaging (NASDAQ:QTI) and Inogen (NASDAQ:INGN) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations, earnings and media sentiment.

QT Imaging has higher earnings, but lower revenue than Inogen. Inogen is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
QT Imaging$18.92M2.12-$21.08M-$1.57N/A
Inogen$348.67M0.43-$22.75M-$0.90N/A

24.2% of QT Imaging shares are owned by institutional investors. Comparatively, 89.9% of Inogen shares are owned by institutional investors. 25.4% of QT Imaging shares are owned by company insiders. Comparatively, 2.5% of Inogen shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Inogen has a net margin of -6.94% compared to QT Imaging's net margin of -77.25%. Inogen's return on equity of -13.17% beat QT Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
QT Imaging-77.25% -1,202.69% -46.76%
Inogen -6.94%-13.17%-8.36%

QT Imaging has a beta of -0.01, indicating that its share price is 101% less volatile than the broader market. Comparatively, Inogen has a beta of 1.55, indicating that its share price is 55% more volatile than the broader market.

In the previous week, QT Imaging and QT Imaging both had 1 articles in the media. QT Imaging's average media sentiment score of 1.92 beat Inogen's score of -0.15 indicating that QT Imaging is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
QT Imaging
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Inogen
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
QT Imaging
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Inogen
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.50

Summary

Inogen beats QT Imaging on 9 of the 15 factors compared between the two stocks.

How does QT Imaging compare to KORU Medical Systems?

KORU Medical Systems (NASDAQ:KRMD) and QT Imaging (NASDAQ:QTI) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, media sentiment, profitability, dividends, valuation and institutional ownership.

KORU Medical Systems presently has a consensus target price of $7.00, indicating a potential upside of 118.07%. Given KORU Medical Systems' stronger consensus rating and higher probable upside, equities analysts clearly believe KORU Medical Systems is more favorable than QT Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
QT Imaging
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 24.2% of QT Imaging shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by insiders. Comparatively, 25.4% of QT Imaging shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, KORU Medical Systems and KORU Medical Systems both had 1 articles in the media. QT Imaging's average media sentiment score of 1.92 beat KORU Medical Systems' score of 0.00 indicating that QT Imaging is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
KORU Medical Systems
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
QT Imaging
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

KORU Medical Systems has a net margin of -4.03% compared to QT Imaging's net margin of -77.25%. KORU Medical Systems' return on equity of -10.63% beat QT Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
KORU Medical Systems-4.03% -10.63% -6.51%
QT Imaging -77.25%-1,202.69%-46.76%

KORU Medical Systems has higher revenue and earnings than QT Imaging. KORU Medical Systems is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KORU Medical Systems$41.13M3.58-$2.64M-$0.04N/A
QT Imaging$18.92M2.12-$21.08M-$1.57N/A

KORU Medical Systems has a beta of 0.45, meaning that its stock price is 55% less volatile than the broader market. Comparatively, QT Imaging has a beta of -0.01, meaning that its stock price is 101% less volatile than the broader market.

Summary

KORU Medical Systems beats QT Imaging on 12 of the 15 factors compared between the two stocks.

How does QT Imaging compare to Apyx Medical?

Apyx Medical (NASDAQ:APYX) and QT Imaging (NASDAQ:QTI) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, risk, earnings, dividends, valuation, profitability and analyst recommendations.

Apyx Medical has a net margin of -14.78% compared to QT Imaging's net margin of -77.25%. Apyx Medical's return on equity of -76.60% beat QT Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
Apyx Medical-14.78% -76.60% -13.91%
QT Imaging -77.25%-1,202.69%-46.76%

Apyx Medical has a beta of 1.39, meaning that its stock price is 39% more volatile than the broader market. Comparatively, QT Imaging has a beta of -0.01, meaning that its stock price is 101% less volatile than the broader market.

55.3% of Apyx Medical shares are held by institutional investors. Comparatively, 24.2% of QT Imaging shares are held by institutional investors. 15.9% of Apyx Medical shares are held by company insiders. Comparatively, 25.4% of QT Imaging shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Apyx Medical and Apyx Medical both had 1 articles in the media. QT Imaging's average media sentiment score of 1.92 beat Apyx Medical's score of 0.92 indicating that QT Imaging is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Apyx Medical
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
QT Imaging
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Apyx Medical presently has a consensus target price of $6.60, indicating a potential upside of 111.54%. Given Apyx Medical's stronger consensus rating and higher possible upside, research analysts clearly believe Apyx Medical is more favorable than QT Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Apyx Medical
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.71
QT Imaging
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Apyx Medical has higher revenue and earnings than QT Imaging. Apyx Medical is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apyx Medical$52.84M2.49-$11.21M-$0.20N/A
QT Imaging$18.92M2.12-$21.08M-$1.57N/A

Summary

Apyx Medical beats QT Imaging on 13 of the 16 factors compared between the two stocks.

How does QT Imaging compare to Microbot Medical?

Microbot Medical (NASDAQ:MBOT) and QT Imaging (NASDAQ:QTI) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, valuation, analyst recommendations, media sentiment and dividends.

Microbot Medical has a beta of 1.06, suggesting that its stock price is 6% more volatile than the broader market. Comparatively, QT Imaging has a beta of -0.01, suggesting that its stock price is 101% less volatile than the broader market.

16.3% of Microbot Medical shares are owned by institutional investors. Comparatively, 24.2% of QT Imaging shares are owned by institutional investors. 4.7% of Microbot Medical shares are owned by insiders. Comparatively, 25.4% of QT Imaging shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Microbot Medical has higher earnings, but lower revenue than QT Imaging. Microbot Medical is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Microbot Medical$346K291.18-$13.14M-$0.24N/A
QT Imaging$18.92M2.12-$21.08M-$1.57N/A

Microbot Medical has a net margin of 0.00% compared to QT Imaging's net margin of -77.25%. Microbot Medical's return on equity of -21.87% beat QT Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
Microbot MedicalN/A -21.87% -20.76%
QT Imaging -77.25%-1,202.69%-46.76%

Microbot Medical currently has a consensus price target of $6.38, indicating a potential upside of 325.00%. Given Microbot Medical's stronger consensus rating and higher probable upside, equities analysts plainly believe Microbot Medical is more favorable than QT Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Microbot Medical
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.80
QT Imaging
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Microbot Medical had 8 more articles in the media than QT Imaging. MarketBeat recorded 9 mentions for Microbot Medical and 1 mentions for QT Imaging. QT Imaging's average media sentiment score of 1.92 beat Microbot Medical's score of -0.50 indicating that QT Imaging is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Microbot Medical
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Negative
QT Imaging
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

Microbot Medical beats QT Imaging on 12 of the 17 factors compared between the two stocks.

How does QT Imaging compare to Kewaunee Scientific?

Kewaunee Scientific (NASDAQ:KEQU) and QT Imaging (NASDAQ:QTI) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, valuation, earnings, analyst recommendations and dividends.

Kewaunee Scientific has higher revenue and earnings than QT Imaging. QT Imaging is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kewaunee Scientific$282M0.38$9.62M$3.2211.51
QT Imaging$18.92M2.12-$21.08M-$1.57N/A

32.7% of Kewaunee Scientific shares are owned by institutional investors. Comparatively, 24.2% of QT Imaging shares are owned by institutional investors. 14.1% of Kewaunee Scientific shares are owned by insiders. Comparatively, 25.4% of QT Imaging shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
QT Imaging
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, QT Imaging had 1 more articles in the media than Kewaunee Scientific. MarketBeat recorded 1 mentions for QT Imaging and 0 mentions for Kewaunee Scientific. QT Imaging's average media sentiment score of 1.92 beat Kewaunee Scientific's score of 0.00 indicating that QT Imaging is being referred to more favorably in the news media.

Company Overall Sentiment
Kewaunee Scientific Neutral
QT Imaging Very Positive

Kewaunee Scientific has a beta of 0.72, meaning that its stock price is 28% less volatile than the broader market. Comparatively, QT Imaging has a beta of -0.01, meaning that its stock price is 101% less volatile than the broader market.

Kewaunee Scientific has a net margin of 3.41% compared to QT Imaging's net margin of -77.25%. Kewaunee Scientific's return on equity of 14.10% beat QT Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
Kewaunee Scientific3.41% 14.10% 5.55%
QT Imaging -77.25%-1,202.69%-46.76%

Summary

Kewaunee Scientific beats QT Imaging on 9 of the 14 factors compared between the two stocks.

Get QT Imaging News Delivered to You Automatically

Sign up to receive the latest news and ratings for QTI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

QTI vs. The Competition

MetricQT ImagingHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$38.28M$5.89B$7.27B$12.76B
Dividend YieldN/A1.75%2.54%11.08%
P/E Ratio-1.8526.30270.6924.20
Price / Sales2.1280.78639.89109.35
Price / CashN/A33.2076.8953.23
Price / Book18.196.2013.436.37
Net Income-$21.08M$149.51M$3.46B$347.74M
7 Day Performance1.04%0.87%2.15%0.06%
1 Month Performance-0.34%8.29%6.18%2.86%
1 Year Performance33.49%7.70%24.96%17.13%

QT Imaging Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QTI
QT Imaging
1.3205 of 5 stars
$2.91
+4.7%
N/A+33.5%$38.28M$18.92MN/AN/A
INGN
Inogen
1.1168 of 5 stars
$5.81
flat
N/A-25.5%$154.19M$348.67MN/A1,030
KRMD
KORU Medical Systems
3.0661 of 5 stars
$3.33
+0.9%
$7.00
+110.2%
-21.9%$151.58M$41.13MN/A80
APYX
Apyx Medical
2.4314 of 5 stars
$3.04
+1.7%
$6.60
+117.1%
+51.5%$125.95M$52.84MN/A270
MBOT
Microbot Medical
1.8916 of 5 stars
$1.68
-3.2%
$6.63
+294.3%
-57.9%$116.53MN/AN/A20

Related Companies and Tools


This page (NASDAQ:QTI) was last updated on 8/22/2026 by MarketBeat.com Staff.
From Our Partners